Download PDF
Exp Clin Endocrinol Diabetes 2013; 121(04): 230-233
DOI: 10.1055/s-0033-1341428
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Effect of Pregabalin on Erectile Function and Penile NOS Expression in Rats with Streptozotocin-Induced Diabetes

S. Amany
1   Associate Professor of Clinical pharmacology, Clinical Pharmacology Department, Faculty of Medicine, Mansoura ­University, Egypt
,
K. Heba
2   Associate Professor of Medical Biochemistry, Medical Biochemistry Department, Faculty of Medicine, Mansoura University, Egypt
› Author Affiliations
Further Information

Publication History

received 28 October 2012
first decision 22 February 2013

accepted 01 March 2013

Publication Date:
17 April 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Objectives:

To investigate the effect of pregabalin on erectile function and on the penile expression of nitric oxide synthase (NOS) isoforms in diabetic rat models.

Methods:

Male Sprague-Dawley rats were injected with streptozotocin to induce diabetes mellitus. The rats with blood glucose levels above 300 mg/dL were selected for the study. Those were randomly divided into 2 groups (N=10 per group): i) EDDM (erectile dysfunction diabetes mellitus )group fed with saline and ii) EDDM+Pregabalin treated group receiving pregabalin (10 mg/k/day) by intragastric administration. 10 animals served as a control group and received no streptozotocin. 4 weeks later, the erectile function of the rats was assessed by recording frequency of erection after subcutaneous apomorphine (80 ug/kg) injection. Superoxide anion generation and the expression of mRNA of nNOS and eNOS were evaluated in corpora cavernosum tissue.

Results:

Penile erection, the expression of both nNOS, eNOS and superoxide generation were significantly decreased in pregabalin treated group compared to control group.

Conclusion:

Treatment with pregabalin for 4 weeks decreases superoxide production but cannot improve erectile dysfunction in diabetic rats probably by inhibiting Ca2  +  channel-mediated NOS activation.

Key words

diabetes - erectile dysfunction - nitric oxide synthase - pregabalin
 

  • References

  • 1 World Health Organization Diabetes. 2011 Fact sheet no. 312
    PubMed
  • 2 Blanco R, Saenz de Tejada I, Goldstein I et al. Dysfunctional penile cholinergic nerves in diabetic impotent men. Journal urology 1990; 144: 278-280
    PubMedGoogle Scholar
  • 3 Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Current Diabetes Reports 2002; 2: 501-509
    CrossrefPubMedGoogle Scholar
  • 4 Musicki B, Burnett AL. Endothelial dysfunction in diabetic erectile dysfunction. International Journal Impotence Research 2007; 19: 129-138
    PubMedGoogle Scholar
  • 5 Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. Journal urology 2003; 170: S6-S13
    PubMedGoogle Scholar
  • 6 Kumar N, Laferriere A, Yu JS et al. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. Journal Of Neurochemistry 2010; 113: 552-561
    CrossrefPubMedGoogle Scholar
  • 7 Stump P. Pregabalin – profile of efficacy and tolerability in neuropathic pain. Drugs Today (Barc) 2009; 45: 19-27
    PubMedGoogle Scholar
  • 8 Bender G, Florian Jr JA, Bramwell S et al. Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. Journal of Pharmacology& Experimental Therapeutics 2010; 334: 599-608
    PubMedGoogle Scholar
  • 9 Park HJ, Joo HS, Chang HW et al. Attenuation of neuropathy-induced allodynia following intraplantar injection of pregabalin. Canadian Journal of Anesthesia 2010; 57: 664-671
    CrossrefPubMedGoogle Scholar
  • 10 Hitiris N, Barrett JA, Brodie MJ. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports. Epilepsy Behavior 2006; 8: 418-421
    CrossrefPubMedGoogle Scholar
  • 11 Chen Y, Yang R, Yao L et al. Differential expression of neurotrophins in penises of streptozotocin-induced diabetic rats. Journal of Andrology 2007; 28: 306-312
    PubMedGoogle Scholar
  • 12 Usta MF, Kendirci M, Gur S et al. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. Journal of Sexual Medicine 2006; 3: 242-250
    CrossrefPubMedGoogle Scholar
  • 13 Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complementary Alternative Medicine 2011; 11: 24
    PubMedGoogle Scholar
  • 14 Heaton JP, Varrin S, Morales A. The characterization of a bioassay of erectile function in a rat model. Journal Urology 1991; 145: 1099-1102
    PubMedGoogle Scholar
  • 15 Wang HD, Pagano PJ, Du Y et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circulation Research 1998; 82: 810-818
    CrossrefPubMedGoogle Scholar
  • 16 Chromczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenolchloroform extraction. Analytical Biochemistry 1987; 162: 156-159
    PubMedGoogle Scholar
  • 17 Kim YW, Choi DW, Park YH et al. Leptin-like effects of MTII are augmented in MSG-obese rats. Regulatory Peptides 2005; 127: 63-70
    CrossrefPubMedGoogle Scholar
  • 18 Vernet D, Cai L, Garban H et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709-5717
    CrossrefPubMedGoogle Scholar
  • 19 Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003; 52: 2353-2362
    CrossrefPubMedGoogle Scholar
  • 20 Cashen DE, MacIntyre DE, Martin WJ. Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase. British Journal of Pharmacology 2002; 136: 693-700
    CrossrefPubMedGoogle Scholar
  • 21 Huang PL, Dawson TM, Bredt DS et al. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273-1286
    CrossrefPubMedGoogle Scholar
  • 22 Burnett AL, Lowenstein CJ, Bredt DS et al. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257: 401-403
    CrossrefPubMedGoogle Scholar
  • 23 Rajfer J, Aronson WJ, Bush PA et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New England Journal Medicine 1992; 326: 90-94
    CrossrefPubMedGoogle Scholar
  • 24 Bivalacqua TJ, Diner EK, Novak TE et al. A rat model of Peyronie’s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. Journal Urology 2000; 163: 1992-1998
    PubMedGoogle Scholar
  • 25 Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertension Research 2011; 34: 5-1
    CrossrefPubMedGoogle Scholar
  • 26 Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-919
    CrossrefPubMedGoogle Scholar
  • 27 Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. Journal Biological Chemistry 1994; 269: 4705-4708
    PubMedGoogle Scholar
  • 28 Sánchez A, Contreras C, Martínez MP et al. Role of Neural NO Synthase (nNOS) Uncoupling in the Dysfunctional Nitrergic Vasorelaxation of Penile Arteries from Insulin-Resistant Obese Zucker Rats. PLoS One 2012; 7
    PubMedGoogle Scholar
  • 29 Azadzoi KM, Golabek T, Radisavljevic ZM et al. Oxidative stress and neurodegeneration in penile ischaemia. Britich Journal Of Urology International 2010; 105: 404-410
    PubMedGoogle Scholar
  • 30 Strong J, Unruh AM, Wright A et al. In: Pain: a textbook for therapists. Elsevier Health Sciences; 2002
    Google Scholar
  • 31 Whiteman M, Armstrong JS, Cheung NS et al. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB Journal 2004; 18: 395-397
    PubMedGoogle Scholar
  • 32 Warfield CA, Bajwa ZH. Principles and practice of pain medicine. McGraw-Hill Professional; 2003
    Google Scholar
  • 33 Gajraj NM. Pregabalin: its pharmacology and use in pain management. Anesthesia Analgesia journal 2007; 105: 1805-1815
    PubMedGoogle Scholar
  • 34 Muthuraman A, Singh N. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. Journal Ethnopharmacology 2012; 142: 723-731
    CrossrefPubMedGoogle Scholar